The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A retrospective study of hepatic arterial infusion (HAI) FUDR/Dex and mitomycin C (MMC) for chemotherapy refractory unresectable intrahepatic cholangiocarcinomas (ICC).
 
Gustavo Dos Santos Fernandes
Consulting or Advisory Role - Bayer; Roche
Research Funding - BMS Brazil; MSD; Roche
Travel, Accommodations, Expenses - Roche
 
Nancy E. Kemeny
Research Funding - Amgen
Patents, Royalties, Other Intellectual Property - AMGEN
 
Haley Hauser
No Relationships to Disclose
 
James J. Harding
Consulting or Advisory Role - Bristol-Myers Squibb; CytomX Therapeutics; Lilly
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Incyte (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Polaris (Inst); Polaris (Inst)
 
Thomas Boerner
No Relationships to Disclose
 
Anna M. Varghese
Consulting or Advisory Role - Roche (I)
Research Funding - BioMed Valley Discoveries; Bristol-Myers Squibb; Illumina (I); Lilly; Silenseed; Verastem
Travel, Accommodations, Expenses - Roche (I)
 
Peter Kingham
No Relationships to Disclose
 
Michael Ian D'Angelica
No Relationships to Disclose
 
Ronald P. DeMatteo
No Relationships to Disclose
 
Jeffrey A. Drebin
No Relationships to Disclose
 
Vinod P. Balachandran
No Relationships to Disclose
 
William R. Jarnagin
No Relationships to Disclose
 
Andrea Cercek
Consulting or Advisory Role - Amgen; Bayer
Research Funding - Abbvie; Amgen; Bayer